Alkosign closes trading window ahead of Q2FY27 results

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026
  • Closure lasts until 48 hours post-results announcement
  • Covers financial results for half year ended September 30, 2026
  • Compliance with SEBI insider trading regulations
powered bylight_fuzz_icon
52229852

*this image is generated using AI for illustrative purposes only.

Alkosign Limited has closed its trading window for dealing in equity shares effective October 1, 2026. The closure will remain in force until 48 hours after the company communicates its financial results for the half year ended September 30, 2026, to the stock exchanges.

This action is taken in compliance with the Code of Conduct for Prevention of Insider Trading under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The restriction prevents designated persons from trading during this sensitive period to ensure fair market practices.

The date of the board meeting scheduled to consider these financial results will be intimated to the stock exchanges in due course. This notice serves as the required disclosure under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Samir Narendra Shah, Managing Director of Alkosign, signed the notice digitally on September 29, 2026. The communication was addressed to the BSE SME Platform Department of Corporate Services.

Historical Stock Returns for Alkosign

1 Day5 Days1 Month6 Months1 Year5 Years
+2.54%0.0%0.0%+3.73%0.0%+106.30%

How might the upcoming H1 FY2027 financial results impact Alkosign's stock volatility once the trading window reopens?

What are the projected revenue growth trends for Alkosign Limited in the chemical sector for the remainder of the fiscal year?

Will the board meeting date announcement trigger any speculative trading activity or analyst coverage changes prior to the results release?

Alkosign Ltd adopts FY26 accounts, re-appoints Samir Narendra Shah as CMD

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Alkosign Limited held its 6th AGM on September 29, 2026, adopting FY26 accounts
  • Statutory Auditors reported no qualifications in the audit report for FY26
  • Samir Narendra Shah re-appointed as Chairman and Managing Director with fixed remuneration
  • Voting conducted via ballot papers as SME-listed companies are exempt from e-voting
powered bylight_fuzz_icon
52218985

*this image is generated using AI for illustrative purposes only.

Alkosign Limited held its 6th Annual General Meeting (AGM) on September 29, 2026, at its registered office in Thane, Maharashtra. The meeting focused on the adoption of audited financial statements for the fiscal year ended March 31, 2026, and the re-appointment of several key directors, including Chairman and Managing Director Samir Narendra Shah.

The Statutory Auditors did not make any qualifications, observations, or comments in their audit report for the year ended March 31, 2026. The meeting was chaired by Samir Narendra Shah, who was elected by the directors present. He welcomed the shareholders and introduced the directors attending the meeting. The Chairman confirmed that the quorum was met before proceeding with the agenda items.

Ordinary Business Resolutions

The members considered and approved the following ordinary business items:

  • Adoption of the annual accounts for FY26.
  • Re-appointment of Zeenal Shrenik Shah (DIN: 03572358) as a retiring director.

Special Business and Director Appointments

A significant portion of the agenda involved special business resolutions related to governance and remuneration. The shareholders approved the re-appointment of key leadership figures and addressed remuneration caps under the Companies Act, 2013.

Director Name DIN Role / Action Status
Samir Narendra Shah 03572442 Chairman and Managing Director Re-appointed with remuneration fixation
Shrenik Kamlesh Shah 03572426 Whole-time Director Re-appointed with remuneration fixation
Parshva Vinaykant Doshi 03408376 Non-Executive Independent Director Re-appointed
Seema Ashim Jhaveri 09431665 Non-Executive Independent Director Re-appointed
Yogesh Ramgopal Gupta 09431193 Non-Executive Independent Director Re-appointed

Additionally, the members approved related party transactions with Senate Office System, a proprietorship firm. The company also sought approval for director remuneration exceeding the overall managerial remuneration limit as per Section 197 of the Companies Act, 2013.

Voting and Compliance Details

Alkosign is listed on the SME platform of the Bombay Stock Exchange (BSE). The Chairman informed members that the company is exempted from e-voting requirements pursuant to an MCA notification dated March 19, 2015, which amended Rule 20 of the Companies (Management and Administration) Rules, 2014. Consequently, voting was conducted via polling papers/ballot papers for members present.

Only members recorded in the Register of Members or Register of Beneficial Owners as of the cut-off date were entitled to vote. The results of the voting are scheduled to be announced within two working days after receiving the report from the scrutinizer. These results will be communicated to the stock exchange and displayed on the company’s website.

The meeting concluded at 1:00 pm with a vote of thanks proposed by Whole-time Director Shrenik Kamlesh Shah.

Historical Stock Returns for Alkosign

1 Day5 Days1 Month6 Months1 Year5 Years
+2.54%0.0%0.0%+3.73%0.0%+106.30%

How will the approval of director remuneration exceeding Section 197 limits impact Alkosign's future cash flow and profitability metrics?

What strategic synergies are expected from the continued related party transactions with Senate Office System, and how might this affect minority shareholder interests?

Given the clean audit opinion for FY26, what specific growth initiatives or capital expenditure plans is the management likely to prioritize in FY27?

More News on Alkosign

1 Year Returns:0.00%